Angiodynamics ANGO

Angiodynamics Inc · Nasdaq · Surgical & Medical Instruments & Apparatus

$12.35+1.81%close on Oct. 29, 2026 · volume 476K · Yahoo Finance

Price, last 48 sessions

$12.00$14.00$16.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 29, 2026 · high $16.13 · low $10.90 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
July 30, 2026Warren Nighan Jr
SVP Quality and Regulatory
Sold23,370$14.72$344,006

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 11 →
  • 10-QOct. 8, 2026, 12:56 p.m. ETView on SEC.gov
  • 8-KOct. 8, 2026, 7:17 a.m. ETView on SEC.gov

    Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedAngioDynamics Q1 FY2027 net sales rise 6.9% to $80.9 million; Med Tech up 13.2%, FY2027 guidance reiterated, CEO transition to Eric Honroth

  • 8-KOct. 8, 2026, 7:16 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Departure/appointment of directors or officers · Financial statements and exhibits

    AI summary, unreviewedAngioDynamics Names Eric Honroth CEO Effective November 2, 2026, Succeeding James Clemmer After Ten Years

  • 10-K/ASept. 29, 2026, 4:01 p.m. ETView on SEC.gov
  • 10-K/ASept. 29, 2026, 9:14 a.m. ETView on SEC.gov
  • 4July 31, 2026, 4:45 p.m. ETView on SEC.gov
  • 4July 24, 2026, 6:10 p.m. ETView on SEC.gov
  • 4July 24, 2026, 6:10 p.m. ETView on SEC.gov